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AEfficient Rescue of Infectious Bursal Disease Virus from Cloned cDNA: Evidence
for Involvement of the 39-Terminal Sequence in Genome Replication
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To study the mechanism of replication of infectious bursal disease virus (IBDV), and to determine factors on the IBDV RNA
which are involved in viral replication, we used cloned full-length cDNA of both the A- and B-segments to generate infectious
IBDV. Infectious IBDV was rescued from plasmids that contained full-length IBDV cDNA behind a T7 promoter, by transfecting
these plasmids into cells which were infected with a recombinant Fowlpox virus that expressed T7 RNA polymerase. By using
the cDNA transfection system we evaluated the effect of the length of the 39 terminus of the A-segment plus strand of IBDV.
Although wild-type IBDV predominantly contains four cytosines at the 39 terminus, no difference in virus yield was found when
virus was rescued from cDNAs containing three to six adjacent cytosines. When the 39 terminus was shorter than three
cytosines the efficiency to generate infectious IBDV from cDNA was reduced, but IBDV could still be recovered reproducibly.
The rescued viruses from cDNAs containing 39-terminal deletions appeared to have a restored 39-terminal sequence. The
missing nucleotides are probably restored by using complementary bases of a stem-loop structure as template. © 1999
Academic Press
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sINTRODUCTION
Infectious bursal disease virus (IBDV) is a member of
he family of Birnaviridae, having a double-stranded RNA
dsRNA) genome divided over two segments (Dobos et
l., 1979). The dsRNA genome is covered by a single
rotein shell, consisting of two viral proteins, which re-
ults in a naked virus particle (60 nm) with an icosahe-
ral (T 5 13) symmetry (Bottcher et al., 1997). IBDV is the
ausative agent of a highly contagious disease among
hickens known as Gumboro disease, named after the
lace where the first outbreak of IBDV was reported in
957 (Cosgrove, 1962; Winterfield and Hitchner, 1962).
BDV replicates specifically in developing B-cells in the
ursa of Fabricius. During this replication, viral proteins
nduce apoptosis, resulting in a rapid depletion of B-cells
Vasconcelos and Lam, 1995). Young birds (,2 weeks of
ge) which are infected with IBDV generally show no
linical signs, but may be immunosuppressed during
heir remaining lifetimes. Chicks between the age of 2
nd 6 weeks show morbidity and mortality as a result of
n IBDV infection.
The largest genomic dsRNA segment (the A-segment)
f IBDV encodes two proteins, VP5 (17 kDa) and a
olyprotein (pVP2 3 VP4 3 VP3, 110 kDa) in two partly
Sequence data from this article have been deposited with the EMBL/
enBank Data Libraries under Accession Nos. AF1g4428 and AF1g442g.
1 To whom reprint requests should be addressed at ID-Lelystad, PO.
ox 65, NL-8200 AB Lelystad, The Netherlands. Fax: 131 320 238 668.c-mail: H.J.Boot@ID.wag-ur.nl.
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330verlapping reading frames (see Fig. 1). The polyprotein
s autocatalytically cleaved into three proteins desig-
ated pVP2, VP3, and VP4. The pVP2 (48 kDa) is further
rocessed into VP2 (38 kDa), during maturation of the
iral particle (Kibenge et al., 1997). Cleavage of pVP2 is
hought to occur by an (extra)cellular protease of the
ost. VP2 is one of the two viral proteins that constitute
he capsid and contains the most prominent neutralizing
pitopes, which are conformation dependent. The VP3
rotein (32 kDa) is the other component of the viral
apsid. The VP4 part of the polyprotein is responsible for
he two proteolytical cleavages which liberate pVP2 and
P3 from the polyprotein. For a long time it was believed
hat VP4 was also part of IBDV virions. Recently it was
hown that a tubular multimeric form of VP4 copurifies
ith viral particles and that the IBDV virions do not
ontain VP4 (Granzow et al., 1997). VP4 of IBDV should
herefore be considered a nonstructural protein, similar
o the corresponding protease (NS protein) of the aqua-
irnavirus infectious pancreatic necrosis virus (IPNV)
hich is also a nonstructural protein (Dobos, 1995a). The
mallest IBDV protein (VP5, 17 kDa), encoded by the
econd ORF of the A-segment, is not essential for viral
eplication and infection. This was independently shown
y both the groups of Mundt (Mundt et al., 1997) and
akharia (Yao et al., 1998), who removed the start codon
f the ORF encoding VP5 and still succeeded in produc-
ng infectious IBDV from the modified cDNA. Although
P5-negative IBDV is still infectious, no pathological le-
ions or clinical signs are present in the bursa of infected
hickens (Yao et al., 1998).
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331INVOLVEMENT OF THE 39-TERMINAL SEQUENCE IN IBDV REPLICATIONSome controversy exists about the nature of the ter-
ini of the genomic and messenger RNA of IBDV. The
resence of a VPg at the 59 end of the positive strands of
he two genomic segments of the birnaviruses has been
hown (Calvert et al., 1991; Mu¨ller and Nitschke, 1987).
hether the 59 termini of the noncoding strands also
ave this covalently linked VPg is not known. The unusu-
lly large VPg (90 kDa) is the same protein as the VP1
rotein encoded by the B-segment, the putative RNA-
ependent RNA polymerase (RdRp). Spies and Mu¨ller
1990) have reported that viral mRNA might contain a cap
tructure at its 59 end, while Dobos reported that VP1
acks the enzymatic activities for generating a cap struc-
ure (Dobos, 1993). In vitro synthesized mRNA containing
cap structure has been used to rescue infectious IBDV
fter transfection into eukaryotic cells (Mundt and
akharia, 1996). However, this result does not prove that
iral mRNA is indeed capped and not VPg-linked. It has
een shown for other viruses that the VPg can be re-
laced by a cap structure to rescue infectious virus from
loned cDNA (Boyer and Haenni, 1994).
To study the replication of IBDV we have rescued
nfectious IBDV (rIBDV) from transfected cDNA as op-
osed to transfection of RNA as described by Mundt and
akharia (1996). By using a recombinant Fowlpox virus
hat expresses T7 RNA polymerase in the cytoplasm of
nfected cells (Britton et al., 1996), we were able to
escue IBDV by transfecting plasmids containing full-
ength cDNA into susceptible cells. Apart from the ad-
antage of transfecting cDNA instead of RNA (see Boyer
nd Haenni, 1994), we found that this system reproduc-
bly yields high titers of rIBDV. By using this cDNA trans-
FIG. 1. Schematic representation of the plasmids containing a full-len
he A-segment (pUC18-AGT). Boxes indicate ORFs and several functio
olymerase promoter and terminator sequences are indicated. The mu
enetic tag (KpnI restriction site) in the A-segment cDNA sequence are
s indicated in pUC18-AGT, which contains the 39-terminal sequence
ibozyme.ection system we evaluated the effect of the length of she 39 terminus of the A-segment plus strand on replica-
ion of IBDV.
RESULTS
ucleotide sequence determination of the 59 termini
To study the mode of replication of the segmented
sRNA genome of IBDV we determined the extreme 59
ermini of both the coding and noncoding strands of the
wo genomic RNA segments of IBDV (cell culture-
dapted classical isolate CEF94) (Table 1). We applied
he 59-RACE technique (rapid amplification of cDNA
nds) (Frohman et al., 1988) to determine the 59-terminal
equences. The RACE analysis was performed at least
wo times independently on each of the four 59 termini of
he IBDV genome. The resulting sequence data (Table 2)
how that the length of the 59 termini of the coding strand
as the same in all clones. Furthermore, we found that
he nucleotide sequence was identical except for the first
ucleotide, which varied in a few clones. This is in
ontrast to the sequence data of the 39 termini of the
oding strands, which varied in length considerably (up
o eight nucleotides). We also found that the last nucle-
tide, although preferably a cytosine, varied in some
lones, just as we found for the 59 end.
eneration of plasmids containing full-length cDNA
We believed that the length variation of the 39 end of
he coding strands was not an experimental artifact, as
e found it for both the A- and B-segments, and no such
ength variation was seen for the 59 end of the coding
V A-segment (pHB-36W), B-segment (virus pHB-34Z), or the 39 UTR of
netic elements, such as hepatitis delta ribozyme (HDR) and T7 RNA
which interferes with the cleavage of the polyprotein (V582A) and the
ed in pHB-36W. The exact position of the cleavage site of the ribozyme
-36W, fused to the 59-terminal sequence of the hepatitis delta virusgth IBD
nal ge
tation
indicat
of pHBtrand. To determine the effect of these variations on the
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332 BOOT ET AL.eplication ability of IBDV we cloned the entire coding
nd noncoding cDNA sequences of the A- and B-seg-
ents (three times independently). By using this se-
uence information, and the consensus sequence for the
9 and 39 termini (Table 2), we generated a consensus
equence for the cDNA of both the A- and B-segments of
he CEF94 IBDV isolate.
One of the cloned A-segments (pHB-36) had only two
ucleotide sequence variations compared to the A-seg-
ent consensus sequence (A1108G and T1875C). The
utation at position nt 1108 (pVP2 encoding part) is a
TABLE 1
Nucleotide Sequences and Positions of the Primers Used
Name Sequence Position
C10 gctctagaaCGTCGATCTACGGGGC A1 (nt 2906)
C11 gctctagaCATGGACGTGGCCCAAAC A1 (nt 2987)
NC10 gctctagAGACAATTAGCCCTGACC A2 (nt 288)
NC11 gctctagaTAGGTCGAGGTCTCTGAC A2 (nt 247)
C9 gctctagaACTtGTGGAAACAAGCGA B1 (nt 2489)
C10 gctctagaTCAAGAACCCACAGACCG B1 (nt 2553)
NC9 gctctagaGTCGGTCTCATACTCCTC B2 (nt 322)
NC10 gctctagaAGACCGTGGCTGCAAAAC B2 (nt 292)
nchor cacgaattcactatcgattctggatccttc —
nchor primer gaaggatccagaatcgatag —
TGP CTTGAGTGAGGtaCCTGGGAG A1 (nt 3161)
TGM GAGACTCCCAGGtaCCTCACTC A2 (nt 3164)
12 GGGGGGACCCGCGAAC A1 (nt 3247)
11 GGGGGACCCGCGAACG A1 (nt 3246)
21 GGGACCCGCGAACGG A1 (nt 3245)
22 GGACCCGCGAACGGAT A1 (nt 3243)
23 GACCCGCGAACGGATC A1 (nt 3242)
24 ACCCGCGAACGGATCC A1 (nt 3241)
25 CCCGCGAACGGATCCA A1 (nt 3240)
Note. Nucleotides which are able to hybridize with the genome of
BDV are given in uppercase; the introduced genetic tag (KpnI restric-
ion site in primers AGTP and AGTM) is underlined.ilent one, while the mutation at position 1875 (VP4 i
Note. Numbers behind specific sequences indicate the number of times eancoding part) leads to a conservative change from a
aline in the consensus amino acid sequence to an
lanine (V582A) in clone pHB-36. As this mutation was
resent in the protease (VP4) of the polyprotein, we
hecked whether the mutant polyprotein was still
leaved into the different viral proteins (i.e., pVP2, VP3,
nd VP4). When plasmid pHB-36 was used as template
n a coupled in vitro transcription/translation reaction in
he presence of 35S-labeled methionine, we observed
ncomplete polyprotein cleavage. Apart from the ex-
ected viral proteins (pVP2, VP3, and VP4) of the fully
leaved polyprotein, intermediate cleaved products and
oncleaved products (full-length polyprotein) were found
fter SDS–PAGE analysis (Fig. 2, lane 1). To characterize
hese intermediate products we immunoprecipitated
hese proteins, by using monoclonal antibodies against
ither pVP2 (Mab 9-6) or VP3 (Mab B-10). Using the
nti-pVP2 Mab we were able to precipitate the full-length
olyprotein (110 kDa) and the pVP2 protein (48 kDa) (data
ot shown). Using the anti-VP3 Mab we were able to
recipitate the full-length polyprotein (110 kDa), a partly
leaved polyprotein (VP4–VP3, 62 kDa), and the free VP3
32 kDa) (data not shown). Both the cleavages between
VP2 and VP4 and between VP4 and VP3 were incom-
lete. The mutation within the VP4 part of the polyprotein
V582A), which is responsible for this incomplete cleav-
ge, apparently affects both processing steps.
Although the viral protease (VP4) of clone pHB-36 is
ble to liberate the structural viral proteins (pVP2 and
P3) from the polyprotein, we were not able to generate
nfectious IBDV virus from this A-segment clone either
sing the protocol described by Mundt and Vakharia
1996) or in our in vivo T7 expression system (see below).
herefore, we restored the amino acid mutation at posi-
ion 582 by exchanging a 472-bp restriction fragment of
n independent A-segment clone, yielding plasmid pHB-
6A. As a result of this exchange, we no longer observedntermediate or noncleaved polyprotein after in vitroTABLE 2
Nucleotide Sequences Corresponding to the 59 and 39 Termini of the Coding Strands of the Two Genomic Segments of IBDV (CEF94)
59 Terminus of the
A-segment coding strand
Complementory sequence
of the 59 terminus of the
A-segment noncoding strand
59 Terminus of the
B-segment coding strand
Complementory sequence of the
59 terminus of the B-segment
noncoding strand
59GGAUACGAUC... (73) ...CGGG39 59GGAUACGAUG... (53) ...GGGGGCCA39
59AGAUACGAUC... ...CGGGUCCC39 59UGAUACGAUG... (23) ...GGGGGCCU39
59UGAUACGAUC... ...CGGGUCCCU39 ...GGGGGCCC39 (23)
...CGGGUCCCC39 (63) ...GGGGGCCCC39 (23)
...CGGGUCCCCCC39 ...GGUGGCCCCC39
...CGGGUCCCCCCU39 ...GGGGGCCCCCC39
...CGGGUCCCCCCC39 ...GGGGGCCCCCG39
onsensus 59GGAUACGAUC... ...CGGGUCCCC39 (nt 3260) 59GGAUACGAUG... ...GGGGGCCCCC39 (nt 2827)ch sequence was obtained.
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333INVOLVEMENT OF THE 39-TERMINAL SEQUENCE IN IBDV REPLICATIONranslation of this A-segment clone (Fig. 2, lane 2). To be
ble to distinguish between wild-type IBDV and in vitro
enerated infectious IBDV (rIBDV) we subsequently in-
roduced a genetic tag in the A-segment cDNA of plas-
id pHB-36A. For this purpose, we introduced a unique
pnI restriction site just downstream the ORF of the
olyprotein, yielding plasmid pHB-36W (Fig. 1). As ex-
ected, this plasmid yields the same viral proteins in an
n vitro transcription/translation reaction as those in the
-segment clone without the genetic tag (Fig. 2).
One of the clones containing the full-length cDNA of
he B-segment differed by only one nucleotide from the
onsensus sequence, deduced from three independent
ull-length B-segment clones. This mutation (nt 2544 C3
) did not lead to an amino acid mutation in the deduced
rotein sequence. The in vitro translation of the VP1 ORF
ielded a full-length VP1 (91 kDa) and some minor prod-
cts which were all smaller in size (Fig. 2, lane 4). All the
abeled proteins could be precipitated with rabbit anti-
FIG. 2. Autoradiogram of a SDS–PAGE analysis of a coupled in vitro
ranscription/translation reaction. Plasmids containing the full-length
-segment pHB-36 (lane 1), pHB-36A (lane 2), and pHB-36W (lane 3) or
full-length B-segment pHB-34Z (lane 4) were used as DNA template
o produce the viral proteins. The positions of the viral (precursor)
roteins are indicated on the left, and the sizes of the marker proteins
Rainbow marker Amersham, lane M) are indicated on the right.P1 antibodies (data not shown), indicating that these vinor translation products resulted from internal initia-
ion or early termination, phenomena known to occur in
n vitro translation reactions (Crisman et al., 1993).
When we used capped mRNA derived from the full-
ength A- and B-segment clones, pHB-36W and pHB34Z,
espectively, we were able to generate infectious rIBDV
data not shown), by using the mRNA transfection proto-
ol described by Mundt and Vakharia (1996).
ntroduction of the HDV ribozyme downstream the
BDV cDNA
The system for generating infectious IBDV from
DNA clones as described by Mundt and Vakharia
1996) is based upon in vitro run-off transcription from
he T7 promoter which is artificially introduced in front
f the cDNA sequence of the IBDV A- and B-segments.
his RNA is subsequently transfected into VERO cells,
fter which infectious IBDV can be harvested from
hese cells. A drawback of this method is that it is
ifficult to generate perfect 39 termini, as restriction
ites have to be used to generate the end points of
un-off transcription. Since we were specifically inter-
sted in the effect of mutations (deletions and addi-
ions) at the 39 terminus of the coding strand, we
nserted the cis-acting hepatitis delta virus (HDV) ri-
ozyme (Chowrira et al., 1994) behind the cDNA se-
uence of both the A- end B-segments (see Fig. 1). By
sing this ribozyme we were able to produce any
esired mutation in the 39 termini of the coding strand,
s the cleavage of this ribozyme solely depends on the
DV sequence which is located downstream of the
leavage site (Chowrira et al., 1994), and only small
ifferences exists between cleavage rates of ri-
ozymes which have a different 21 nucleotide (Been
nd Wickham, 1997).
owlpox T7 polymerase expression system
In order to start translation of viral proteins and hence
eplication of the viral RNA, capped mRNA has to be
ransfected into eukaryotic cells in the in vitro based
RNA transfection system (Mundt and Vakharia, 1996).
he in vitro production of high-quality capped mRNA is
oth inefficient and expensive. Furthermore, expression
evels from transfected mRNA are generally low due to
he short half-life of mRNA and are not very reproducible,
hich is probably due to the difference in quality of
ifferent mRNA batches.
To circumvent the drawback of generating in vitro
apped RNA, we used an in vivo-based T7 expression
ystem (eukaryotic cells expressing functional T7 poly-
erase) to generate viral RNA from plasmids containing
ull-length IBDV cDNA clones. A prerequisite is that the
enerated viral RNA has to be recognized by the trans-
ation machinery as a template for the production of the
iral proteins. In our laboratory we recently used an in
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334 BOOT ET AL.ivo Fowlpox T7 (FPV-T7) expression system (Britton et
l., 1996) to generate infectious Newcastle disease virus
NDV) from a plasmid containing a full-length NDV cDNA
Peeters et al., 1999). A drawback of the in vivo-based T7
xpression system can be that both Fowlpox T7 and
escued virus (either IBDV or any other virus) are present
n the supernatant of transfected cells. To purify IBDV
rom a mixture of IBDV and Fowlpox virus we made use
f the fact that there is a large difference in size between
BDV (,70 nm) and Fowlpox (.200 nm) particles. By
iltration through a 200-nm filter we are able to remove
he Fowlpox virus completely from a mixture of IBDV and
owlpox T7 virus.
To explore the suitability of using this FPV-T7 system
or the production of infectious IBDV from cloned cDNA,
e first verified whether an infection of QM5 cells with
owlpox (FPV-T7) affected transcription and/or replica-
ion of IBDV. To test this, we infected fresh QM5 cells
ither first with FPV-T7 (m.o.i. . 3) and subsequently with
BDV (m.o.i. 5 0.1) or with IBDV (m.o.i. 5 0.1) alone. After
4 and 48 h of infection the IBDV titers in the superna-
ants were determined and appeared to be similar (data
ot shown), indicating that the Fowlpox infection did not
FIG. 3. Detection of IBDV proteins in transfected monolayers using m
onfluent) were transfected with plasmids containing the A- or B-segm
edium and placed in an incubator (37°C, 5% CO2) for 24 h. The IBDV pr
IPMA). Transfections were performed with plasmids: (A) no plasmids,
nd (F) pHB36W 1 pHB-34Z.nfluence the propagation of IBDV. 2enerating infectious IBDV using FPV-T7-infected
ells
To detect IBDV-specific proteins after transfection of a
lasmid containing the full-length A- or B-segment, we
sed a polyclonal rabbit serum directed against either
P3 or VP1 protein of IBDV in an immunoperoxidase
onolayer assay (IPMA). After transfection of a plasmid
ontaining an A-segment (pHB-36, pHB-36A, or pHB-
6W) we were able to detect the VP3 protein at 24 h after
ransfection in 10 to 50% of the QM5 cells (Figs. 3B,
D–3F). In the case of transfection of a plasmid contain-
ng a B-segment (pHB-34Z), the same number of cells (10
o 50%) were found to express VP1 (Fig. 3C). To screen
or infectious IBDV after transfection of QM5 cells with a
ombination of plasmids encoding the A- and B-seg-
ents, we transferred a part of the supernatant (10% of
he volume) onto fresh QM5 cells. When pHB-36A or
HB-36W was used in combination with pHB-34Z we
ere able to recover infectious rIBDV (TCID50 of about
.0, see Table 3). The presence of rIBDV after transfec-
ion was also evident from the appearance of cytopathic
ffect (CPE) in the transfected QM5 monolayer (within
nal antibodies against VP1 (C) or VP3 (A, B, and D–F). QM5 cells (80%
NA of CEF94. After transfection, the cells were incubated with fresh
were visualized by performing an immunoperoxidase monolayer assay
-36W, (C) pHB-34Z, (D) pHB-36 1 pHB-34Z, (E) pHB-36A 1 pHB-34Z,onoclo
ent cD
oteins
(B) pHB4 h) and the capability of almost all cells in the mono-
l
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335INVOLVEMENT OF THE 39-TERMINAL SEQUENCE IN IBDV REPLICATIONayer to bind antibodies directed against IBDV proteins
Fig. 4). No infectious IBDV was recovered from transfec-
ions with pHB-36 in combination with pHB-34Z (Fig. 4A
nd Table 3). The mutation present in the polyprotein of
HB-36 (V582A) is apparently lethal. Viral dsRNA was
solated from QM5 cells that had been infected with
IBDV originating from a transfection with pHB-36W in
ombination with pHB-34Z. The 39 UTR of the A-segment
as amplified in a RT–PCR and subsequently se-
uenced. The artificially introduced KpnI site (genetic
ag) was indeed present in the 39 UTR (data not shown),
roving that the recovered virus indeed originated from
ur cDNA clones.
T
Effect on Replication of the Sequence of the 39 T
Plasmid Sequence of 39 terminus
HB-36b ...GTTCGCGGGTCCCC
HB-36W12 ...GTTCGCGGGTCCCCCC
HB-36W11 ...GTTCGCGGGTCCCCC
HB-36W1U ...GTTCGCGGGTCCCCU
HB-36W ...GTTCGCGGGTCCCC
HB-36W21 ...GTTCGCGGGTCCC
HB-36W22 ...GTTCGCGGGTCC
HB-36W23 ...GTTCGCGGGTC
HB-36W24 ...GTTCGCGGGT
HB-36W25 ...GTTCGCGGG
HB-36W26 ...GTTCGCGG
HB-36W28 ...GTTCGC
Note. Derivatives of plasmids pHB-36W (A-segment) were transfecte
he resulting IBDV titer was determined 24 h after transfection. Transf
ndependently (TCID50 (1) to (4)), and the averages of the TCID50 deter
a 50% tissue culture infective doses (TCID50) is as 10 Log values.
b pHB-36, which contains a lethal mutation in VP4, was used as a n
FIG. 4. Detection of IBDV using monoclonal antibodies against VP3. S
onolayer (80% confluent). After incubation at room temperature for 1
nd placed in an incubator (5% CO2, 37°C) for 24 h. IBDV was detected
HB-34Z (A), pHB-36A 1 pHB-34Z (B), or pHB36W 1 pHB-34Z (C) was used.ffect of mutations at the 39 terminus of the coding
trand of the A-segment
To study the effect of length variations in the A-seg-
ent 39 terminus of the coding strand on virus replica-
ion, we mutated the 39 terminus in the A-segment in
HB-36W. By using specific primers in a PCR we gener-
ted DNA fragments having a longer or shorter 39 termi-
us. We first introduced the obtained fragments in a
lasmid (pUC18-AGT) that contained only a small part of
he complete A-segment by using the SmaI restriction
ite between the 39 terminus of the cDNA and the HDV
ibozyme (Fig. 1). After confirmation of the correct se-
us of the Coding Strand of the IBDV A-segment
TCID50
a
2 3 4 Average
0.0 0.0 0.0 0.0
6.8 6.8
7.0 5.9
6.5 6.1
5.9 5.9
6.3 6.4
4.3 3.9
2.8 2.6
0.0 0.0 1.5 —
2.7 0.0 0.0 —
0.3 0.0 0.0 —
2.8 1.5 1.5 —
mbination with pHB-34Z (B-segment) into IBDV-susceptible cells and
and titer determinations were performed in duplicate or quaduplicate
ns were calculated (Average).
control is these experiments.
tant of transfections (see Figs. 3D–3F) was used to cover a fresh QM5
onolayers were washed twice with PBS, covered with fresh medium,
rforming an IPMA. Supernatant of transfection with plasmid pHB-36 1ABLE 3
ermin
1
0.0
6.7
4.8
5.3
5.8
6.5
3.4
2.3
0.0
0.0
2.5
0.0
d in co
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minatiouperna
h, the m
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336 BOOT ET AL.uence, we subsequently introduced these length vari-
nts into the full-length A-clone, yielding plasmids pHB-
6W12 to 28 (Table 3).
The pHB-36W12 to 28 derivatives of the wild-type
-segment plasmid were transfected into FPV-T7-in-
ected QM5 cells in combination with a full-length B-
egment plasmid (pHB-34Z). After transfection (24 h), we
etermined the rIBDV TCID50 in the supernatant of the
ransfected cultures (Table 3). The results showed that
here was only minor variation between the obtained
CID50 values of the cDNA variants that encode three,
our, five, or six adjacent cytosine residues at the 39
erminus. The variant A-segment cDNA, which has only
wo cytosines at the 39 terminus, seems to generate
nfectious rIBDV with a reduced efficiency, since the
BDV titer was about 100-fold lower compared to that
ecovered from wild-type cDNA. If the 39 terminus was
urther shortened to one cytosine, the corresponding
CID50 was further decreased (TCID50 5 2.6). However,
oth independent transfections still gave rise to replicat-
ng virus. Further shortening of the 39 terminus lead to
CID50 values that differed considerably between the
ndependent transfections. In several cases no infec-
ious IBDV could be recovered.
To determine whether the introduced length mutations
f the 39 terminus were maintained during replication of
he rIBDV, we determined the nucleotide sequence of the
9 terminus of the A-segment of rIBDV generated from
everal pHB-36W-derived plasmids. This analysis
howed that all of the obtained rIBDV had a wild-type-like
istribution of 39-terminal sequences of the A-segment
oding strand (Table 4).
DISCUSSION
In contrast to previous reports, which describe studies
bout birnavirus replication where data were obtained by
sing biochemical approaches (Dobos, 1995b; Kibenge
nd Dhama, 1997; Kordyban et al., 1997; Spies and Mu¨l-
er, 1990), in this study we have used a genetic approach
o obtain fundamental knowledge about factors impor-
T
Nucleotide Sequences of the 39 Termini of the A-segment Plus Stra
pHB-36W (rIBDV20), pHB-36W22 (rIBDV22),
rIBDV12 rIBDV20 r
GGUCCC GGGUCCC (23) GGG
GGUCCCC (53) GGGUCCCC (73) GGG
GGUCCCCC GGGUCCCCC (23) GGG
GGUCCCCCC GGG
Note. Numbers behind sequences indicate the total number of timeant for viral replication. First we determined the 59- terminal sequences of the coding and noncoding strands
f both the A- and B-segments of a cell culture-adapted
lassical isolate of IBDV (CEF94) by using a segment-
nd strand-specific RACE analysis. For the coding
trands we found that all clones had a 59-terminal se-
uence with a defined length. Both the 59 termini of the
oding strand of the A- and B-segments start with the
equence 59GGAUACGAU, with an occasional exception
oncerning the first base (see Table 2). On the other
and, the 39 terminus of the coding strands showed
onsiderable length variation since more or fewer cyto-
ine residues were found. Mundt and Mu¨ller (1995) de-
ermined the terminal sequences of several IBDV iso-
ates by using polyadenylation of isolated dsRNA to de-
ermine the 39-terminal sequence of the coding strands
f both the A- and B-segments. For the 39-terminal se-
uence of the coding strand of the A-segment, they found
uracil as terminal base, while in case of the B-segment
hey found a cytosine as terminal base. When we used
olyadenylation of the coding strand of the A-segment
nd determined subsequently the 39-terminal sequence
f the elongated RNA we also quite frequently (about
0% of the clones) found a uracil as terminal base (data
ot shown). This discrepancy might be the result of the
act that the 59 terminus of the noncoding strand differs
lightly from the complementary 39 terminus of the cod-
ng strand in some virions. This difference might also be
ue to the different methods used to determine this
equence, as it is known that reverse transcriptase has
erminal transferase activity which can add non-tem-
late-encoded nucleotides to the ends of cDNA (Patel
nd Preston, 1994).
The complete genomic sequence, including the 59 and
9 untranslated regions, of the aquabirnavirus IPNV has
een reported (Kordyban et al., 1997). Nucleotide se-
uence alignments of the complete genomes of IBDV
nd IPNV yields only 57% identity. Although the overall
equence identity is not very high, four of the five first
9-terminal nucleotides and seven of the eight last nu-
leotides of the 39 terminus of the coding strands of both
fectious IBDV, Generated by the Plasmids pHB-36W12 (rIBDV12),
W25 (rIBDV25), and pHB-36W28 (rIBDV28)
2 rIBDV25 rIBDV28
GGGUCCCC (23) GGGUCCC
(43) GGGUCCCT GGGUCCCC (43)
T GGGUCCCTT GGGUCCCCC
CCC GGGUCCCCT GGGUCCCCCC (43)
GGGUCCCCCC GGGUCCCCCCC
GGGUCCCCCCT
his sequence was observed.ABLE 4
nd of In
pHB-36
IBDV2
UCCC
UCCCC
UCCCC
UCCCChe A- and B-segments of IPNV and IBDV are conserved,
s
r
d
f
p
t
I
s
D
o
t
g
h
1
t
i
t
t
p
w
r
I
(
n
u
m
t
t
m
a
r
s
t
e
n
t
c
c
e
s
a
c
r
m
w
p
t
a
m
t
t
t
p
n
t
t
o
d
p
g
a
d
p
e
r
i
3
l
c
w
c
s
o
B
s
c
a
s
e
f
m
l
o
t
1
s
v
l
t
c
M
a
c
s
e
337INVOLVEMENT OF THE 39-TERMINAL SEQUENCE IN IBDV REPLICATIONuggesting a functional role for these nucleotides in viral
eplication. Conserved bases at the 59 and 39 ends of the
ifferent RNA segments of rotaviruses have also been
ound, and these conserved bases are able to bind viral
roteins (Poncet et al., 1993; Patton, 1996). Another no-
able characteristic in the cDNA alignment of IBDV and
PNV is that all of the 59 termini (coding and noncoding
trands) start with at least two adjacent G residues.
obos has shown that the genome-linked protein (VPg)
f IPNV can covalently bind one or two guanine nucleo-
ides (VPg-G or VPg-GG) without the presence of any
enomic template (Dobos, 1993). A similar observation
as been made for VP1 of IBDV (Kibenge and Dhama,
997). The presence of two adjacent guanines at the 59
ermini of several birnaviruses, in combination with the
ntrinsic guanine linkage of VP1 (5VPg) suggests a pro-
ein-primed initiation of both plus and minus strand syn-
hesis. The protein-primed initiation of transcription hy-
othesis is further supported by our experimental data,
hich showed that the removal of all of the cytosine
esidues at the 39 end of the A-segment plus strand of
BDV only yields infectious virus at a very low efficiency
see Table 3, pHB-36W-4). The protein-primed initiation of
oncoding strand synthesis might also explain why the
racil residue as 39-terminal base of the coding A-seg-
ent strand is not found when the sequence of the 59
erminus of the noncoding strand is determined. Produc-
ion of plus strand RNA is different from the production of
inus strand RNA, since double-stranded RNA serves
s template for plus strand synthesis (semiconservative
eplication (Mertens et al., 1982)) whereas single-
tranded RNA serves as template for minus strand syn-
hesis. The fact that a defined length is found for the 59
nd of the coding strand, in contrast to the 59 end of the
oncoding strand, might result from this difference in
emplate composition (ssRNA versus dsRNA).
From the transfection experiments with A-segment
DNAs containing a variable 39-terminal sequence, we
onclude that the exact length of the 39 terminus is not
ssential for viral replication (Table 3). Transfection of
usceptible cells with cDNA coding for length variations
t the 39 terminus, ranging from six to one adjacent
ytosine residues, reproducibly generated infectious
IBDV in all cases. These variations are apparently per-
itted at the 39 terminus of the A-segment coding strand
ithout losing the capability of efficient replication. All
lasmids having deletions beyond the cytosine tract at
he 39 terminus generated rIBDV (pHB-36W25 to 28),
lthough not in each independent transfection experi-
ent. Transfections with plasmid pHB-36, which con-
ains a lethal mutation in the VP4 region of the polypro-
ein, never yielded infectious virus, indicating that rIBDV
hat was occasionally isolated from transfections with
lasmids having 39-terminal deletions of more than four
ucleotides is not due to contamination. The low rIBDViter obtained in these transfection experiments could be ahe result of rIBDV replicating with a very low efficiency,
r it could be the result of a rare event of repair of the
eletions at the 39 terminus. The fact that in some inde-
endent transfections no rIBDV could be recovered ar-
ues against the explanation of a slowly replicating vari-
nt of IBDV. In the case of a rare reversion event a
iscrepancy between independent transfections is ex-
ected, as reversion might occur in one transfection
xperiment, but not in another transfection experiment.
IBDV which was recovered from the transfection exper-
ments with pHB-36W12, pHB-36W, pHB-36W22, pHB-
6W25, and pHB-36W28 was amplified on QM5 mono-
ayers and the 39-terminal sequence of the A-segment
oding strand was determined. This analysis showed a
ild-type distribution of the terminal sequence in all
ases analyzed (Table 4).
Computer-assisted calculations (Mfold program, ver-
ion 3.0; Zuker, 1989) of the minimal energy of the sec-
ndary structure of the coding strands of the IBDV A- and
-segments show that the 39 termini are able to form
table stem-loop structures (Fig. 5). These stem-loops
an function as a structure to protect against exonucle-
se attack of the 39 end. Another possible function of the
tem-loop structure is the binding of either host or virus-
ncoded proteins that assist in transfer of ribosomal
actors from the 39 end to the 59 end of the same viral
RNA (Gallie et al., 1996; Piron et al., 1998). The stem-
oop structures might also have a function in the initiation
f minus strand synthesis. The predicted stability of
hese stem-loop structures is about the same (11.3 vs
1.7 kcal/mol) and in both predictions the last two (A-
egment) or three (B-segment) nucleotides are not in-
olved in stem formation. The stem part of this hairpin-
ike structure consists mainly of GC basepairs. The 39
ermini of the coding strands of the IPNV genome are
FIG. 5. Prediction of the secondary structure of the 39 terminus of the
oding strand of the A- and B-segments of IBDV using version 3.0 of the
fold program (Zuker, 1989). Both the 39 termini are predicted to fold in
stable stem-loop structure. The last nucleotides (two cytosines in the
ase of the A-segment and three cytosines in the case of the B-
egment) are not involved in the stem formation and are predicted to be
xposed.lso predicted to fold into a hairpin structure (data not
s
o
(
t
o
I
a
s
v
r
s
f
w
m
t
(
w
a
b
f
2
c
n
v
t
l
f
t
c
e
g
w
i
d
f
T
b
t
i
i
t
r
p
p
c
b
t
t
p
T
o
r
q
3
g
V
a
i
p
f
O
D
m
N
T
r
L
t
K
a
v
s
p
m
C
I
g
m
s
m
1
s
a
a
(
(
3
(
c
w
2
i
d
L
(
R
c
s
g
s
a
t
338 BOOT ET AL.hown). Although the energy of the hairpin-like structure
f the IPNV A- and B-segments differs considerably
212.2 and 28.7 kcal/mol, respectively) both stem struc-
ures mainly consist of GC basepairs, just as in the case
f IBDV. The 39 termini of the coding strands of IBDV and
PNV show considerable length variations (see Table 2
nd Kordyban et al., 1997; Mundt and Muller, 1995). We
how that the last few nucleotides, which are not in-
olved in base pairing, are also not essential for viral
eplication. This may indicate that not the exact length (or
equence) of the 39 terminus is essential, but rather the
ormation of the predicted stem-loop structure.
For IPNV it has been found that additional nucleotides,
hich were introduced at the 39 terminus of the A-seg-
ent by in vitro run-off transcription, were not present in
he rescued IPNV after transfection into susceptible cells
Yao and Vakharia, 1998). We found a reversion to the
ild-type 39-terminal sequence not only in the case of
dditional nucleotides encoded by the A-segment cDNA,
ut also in the case where nucleotides were removed
rom the 39 terminus of the cDNA sequence (pHB36W22,
5, and 28). This restoration of the wild-type sequence
an be explained by the fact that most of the missing
ucleotides are part of the stem structure (Fig. 5). The
iral RNA-dependent RNA polymerase (VP1) is present in
ransfected cells and might be able to repair the stem-
oop structure by using one half of the stem as template
or synthesis of the complementary half. In the case of
ransfection with plasmid pHB36W28, the deletion in-
ludes all of the conserved nucleotides found at the 39
nd of the A- and B-segments of both IPNV and IBDV. The
uanine at position 27 of the A-segment is basepairing
ith a uracil in the wild-type situation (Fig. 5). Surpris-
ngly, in the virus that was recovered from two indepen-
ent transfections with plasmid pHB36W28, we also
ound the uracil–guanine basepair at the same position.
he reason for the incorporation of a noncomplementary
ase might be that a uracil–adenine basepair increases
he stability of the stem-loop structure too much, result-
ng in a nonviable virus. It has been shown that increas-
ng or decreasing the stability of a stem-loop structure in
he HIV-1 genome can have a profound effect on genome
eplication of HIV-1 (Das et al., 1997). Alternatively, the
resence of the U-G basepair may also result from the
resence of uncleaved HDV ribozyme. The first five nu-
leotides of the 59 terminus of the cis-acting HDV ri-
ozyme are able to basepair with the remaining part of
he stem structure in the case of pHB36W28, yielding
he same stem-loop structure, including the U-G base-
air, as found in case of wild-type RNA (Figs. 1 and 5).
he transacting RdRp (VP1) may already start replication
n the pHB36W28-derived RNA from which the HDV
ibozyme has not been cleaved. The 39-terminal se-
uence of the uncleaved pHB36W28 RNA resembles the
9-terminal sequence of pHB36W23, which was found to
ive rise to rIBDV with an average TCID50 of 2.6 (Table 3). mMATERIALS AND METHODS
iruses, cells, and monoclonal antibodies
The IBDV isolate CEF94 is a derivative of PV1 (Petek et
l., 1973). After receiving the PV1 isolate in our laboratory
n 1973, we further adapted this isolate by repeated
assage (.25 times) on either primary chicken embryo
ibroblast (CEF) cells or bursa cells. QM5 cells (Antin and
rdahl, 1991) were received from the laboratory of R.
uncan (Dalhouse University, Halifax, Canada) and
aintained in QT35 medium (Fort-Dodge, Weesp, The
etherlands). Recombinant Fowlpox virus containing the
7 polymerase gene (FPV-T7) (Britton et al., 1996) was
eceived from the laboratory of M. Skinner (Compton
aboratory, Berks, United Kingdom). The monoclonal an-
ibody against the pVP2 protein (Mab 9-6) was a gift of
. J. Fahey (CSIRO, Victoria, Australia), while the Mab
gainst VP3 (Mab B-10) was a gift from H. Mu¨ller (Uni-
ersity of Leipzig, Leipzig, Germany). A polyclonal anti-
erum against VP3 was produced by injecting mice with
urified VP3 expressed in Escherichia coli from a plas-
id that contained the ORF encoding VP3 of CEF94 (E.
laassen, unpublished results).
solation of IBDV RNA
Primary chicken embryo fibroblast (CEF) cells were
rown to confluency in GMEM/EMEM (1:1) comple-
ented which 2.5% fetal calf serum and 2% antibiotics
olution ABII (1000 U/ml penicillin, 1000 mg/ml strepto-
ycin, 20 mg/ml fungizone, 500 mg/ml Polymixin B, and
0 mg/ml kanamycin), and infected with CEF94 until
evere CPE was apparent (usually between 24 to 48 h
fter transfection). The cell culture (250 ml) was frozen
nd thawed once and centrifuged for 15 min at 6000 g
RT). The supernatant was transferred to JA25.50 tubes
Beckman) and centrifuged at 20,000 rpm (33,000 g) for
h. The virus containing pellet was resuspended in PBS
2.5 ml). To liberate the viral dsRNA from the viral parti-
les, Proteinase K (1.0 mg/ml, Amresco) and SDS (0.5%)
ere added and the mixture was incubated at 50°C for
h. The viral RNA was purified by phenol/chloroform/
soamyl alcohol extraction (two times) and the genomic
sRNA was precipitated by either ethanol/NaCl or 4.0 M
iCl. The pellet was dissolved in DEPC-treated water
0.25 ml) and stored at 220°C until further use.
apid amplification of cDNA ends
To determine the 59 termini of all RNA strands (the
oding and noncoding strands of both the A- and B-
egments) of the CEF94 isolate, we used 2.0 mg of
enomic RNA and 10 pmol of a strand- and segment-
pecific primer (AC10, ANC10, BC9, or BNC9, Table 1) in
total volume of 12 ml. After incubation at 95°C for 5 min
his mixture was immediately transferred onto ice and 4
l of Superscript II first strand synthesis buffer (Gibco/
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339INVOLVEMENT OF THE 39-TERMINAL SEQUENCE IN IBDV REPLICATIONRL), 2 ml of 100 mM DTT, and 2 ml of dNTPs (10 mM
ach) were added. This mixture was subsequently incu-
ated at 52°C for 2 min, after which 1 ml of reverse
ranscriptase (Superscript II; Gibco/BRL) was added and
ncubation at 52°C was continued for 1 h. The reverse
ranscription reaction was stopped by adding 1 ml of 0.5
EDTA. The genomic dsRNA was destroyed by addition
f 2 ml of 6 M NaOH and incubation at 65°C for 30 min.
or neutralization of the mixture, 2 ml of 6 M acetic acid
as added, and cDNA was recovered by using a Qiaex
NA extraction kit (Qiagen) and dissolved in 6 ml water.
In the anchor ligation reaction we used 2.5 ml of the
DNA preparation, 4 pmol of the anchor, 5 ml of T4 ligase
uffer, and 0.5 ml (5 units) of T4 RNA ligase (New England
iolabs). Incubation was performed at room temperature
or 16 h and the mixture was stored at 220°C. To amplify
he single-stranded cDNA which was ligated to the an-
hor, we used nested primers (AC11, ANC11, BC10, and
NC10, Table 1) in combination with the anchor primer.
he PCR for primers AC11, ANC11, and BNC10 was
erformed under the following conditions: 10 pmol of
ach specific primer, 10 pmol of the anchor primer, 4.5
M MgCl2, 1pTaq buffer (Perkin–Elmer), 50 mM each
NTP and 3 units of Taq polymerase (Perkin–Elmer), in a
otal volume of 50 ml. The amplification was performed in
5 cycles through the different temperature levels: 92°C
or 45 s, 57°C for 45 s, and 72°C for 90 s. For the
ombination of primer BC10 and the anchor primer a
ybridization temperature of 65°C and 5.5 mM MgCl2
ere used. The resulting PCR products were gel purified
nd digested with EcoRI and XbaI and ligated (T4 DNA
igase, Pharmacia) in a pUC18 vector that had been
igested with the same restriction enzymes. The result-
ng plasmids were amplified in E. coli and sequence
nalysis was performed by using M13F/R primers.
eneration of full-length A- and B-segment clones
To produce full-length single-stranded cDNA of both
he A- and B-segments we used primers specific for the
9 end of the coding strand in reverse transcription (Boot
t al., 1999). Two primers specific for the 39 ends of both
he coding and noncoding sequences were subse-
uently used to amplify the full-length A- and B-segment
DNAs in a PCR amplification using a mixture of Taq and
wo enzymes (Expand, Boehringer-Mannheim). Three
ndependent RT–PCR reactions were performed for each
egment and the resulting PCR fragments were cloned
nto the pGEM-T-vector (Promega) and amplified in E.
oli. Sequence analysis was performed on both strands
sing sequence specific primers in a cycle sequencing
eaction (BigDye terminator kit, PE Applied Biosystems)
sing an ABI310 apparatus (PE Applied Biosystems). By
sing the EcoRI and SmaI restriction sites, we subse-
uently transferred the full-length A- and B-segment se-
uences to a pUC18-based vector, which contained the 3is-acting HDV ribozyme (Chowrira et al., 1994) and a T7
olymerase terminator (see Fig. 1). One of the A-segment
lones (pHB-36) contained a nucleotide mutation that
esulted in an amino acid substitution (V582A). This mu-
ation was restored to the consensus amino acid encod-
ng sequence by transferring a 472-bp restriction frag-
ent (from nt 1760 to 2232, using restriction sites AflII
nd SacII) of an independent A-segment clone, yielding
lasmid pHB-36A. The replacement was confirmed by
ucleotide sequence analysis of the exchanged region.
odification of the A-segment plasmids
To distinguish infectious virus of cloned cDNA (rIBDV)
rom wild-type virus, we introduced a genetic tag in the 39
TR of the A-segment. Two nucleotides of pHB-36A were
utated (3172C3 T and 3173T3 A3), thereby introduc-
ng a unique KpnI restriction site GGTAAC (see Fig. 1).
his mutation was introduced by the method described
y Higuchi (1990) using mutant primers AGTP and AGTM
nd matching primers M13F and AC10 (Table 1). A
83-bp fragment of the resulting PCR fragment was li-
ated (Rapid ligation kit, Boehringer-Mannheim) into the
ull-length A-segment clone (pHB-36A) by using two
nique restriction sites (BglII and BlpI). The resulting
lasmid (pHB-36W) was amplified in E. coli. The pres-
nce of the genetic tag in the full-length A-segment clone
as confirmed by sequence analysis and digestion with
pnI (data not shown).
n vitro transcription and translation
Plasmids pHB-36 (or derivatives) and pHB-34Z (0.2 mg)
ere used as templates in a 10-ml in vitro transcription–
ranslation reaction (TnT-T7Quick, Promega) in the pres-
nce of [35S]methionine. The resulting viral proteins were
ither immunoprecipitated using monoclonal antibodies
gainst either pVP2 or VP3 or were directly used for
eparation on a SDS–PAGE gel (12%). The [35S]methi-
nine-labeled viral proteins were visualized by autora-
iography.
ransfection of QM5 cells
QM5 cells were grown to 80% confluency in 60-mm
ishes and infected with FPV-T7 (m.o.i. 5 3). After 1 h, the
ells were washed once with 5 ml QT-35 medium and
wice with 2 ml Optimem 1 (Gibco/BRL). In the meantime,
NA (2.0 to 4.0 mg) was mixed with 25 ml LipofectAMINE
Gibco/BRL) in 0.5 ml Optimem 1 and kept at room
emperature for at least 30 min. The QM5 cells were
overed with 4 ml of Optimem 1 and, after addition of the
NA/LipofectAMINE mixture, incubated at 37°C and
.0% CO2 for 18 h. Subsequently, the cells were rinsed
ith PBS, and the cells incubated in complete medium at7°C (5.0% CO2) for another 24 h.
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340 BOOT ET AL.eneration of 39-end mutant A-segment clones
To generate length variations at the 39 terminus of the
oding strand of the A-segment we used PCR mutagen-
sis. Primers with different lengths (see Table 1) which
re able to hybridize with the 39 terminus of the coding
trand of the A-segment were used in combination with
n oligo (AC11) which is able to hybridize with the non-
oding coding strand at position 2998–3015. The result-
ng PCR fragments were ligated (Rapid DNA ligation,
oehringer-Mannheim) in a derivative of the full-length
lone (pUC18-AGT) containing only the 39 UTR of the
-segment, in combination with the HDV Ribozyme (see
ig. 1). The PCR products were digested with KpnI (ge-
etic tag restriction site) and ligated in pUC18-AGT that
ad been digested with KpnI and SmaI. The cloned PCR
ragments were subsequently introduced into the full-
ength A-segment clone by using two unique restriction
ites (KpnI and BlpI), yielding plasmids pHB-36W12 to
HB-36W28. To confirm the correct nucleotide se-
uence of the pHB-36W derivatives, we determined the
ucleotide sequence of the exchanged part (KpnI/BlpI
ragment). Two independently obtained plasmids of each
HB-36W derivative were used for transfection of QM5
ells.
econdary structure prediction
The secondary structure of the two coding strands of
he IBDV genome was predicted by using version 3.0 of
he Mfold program of Zuker (1989). To reduce the total
ength of the A-segment below 3000 nt, which is the
aximum value accepted by the Mfold program, we
eleted 300 nucleotides from this sequence. This dele-
ion was created at three different places; nt 1300 to
600, 1600 to 1900, and 1900 to 2200. The most likely
tructures (lowest energy value) of the three A-segment
eletion clones were determined independently. The pre-
ented stem-loop structure of the A-segment 39 UTR (Fig.
) is found in all of the 10 most likely structures, irrespec-
ive of the position of the deletion. The complete se-
uence of the B-segment (2827 nt) is within the maxi-
um value of the Mfold program. Of the 20 most likely
econdary structures of the complete B-segment coding
equence, 13 have the stem-loop structure shown in Fig.
. In the remaining predictions the 39 terminus of the
oding B-segment strand folded slightly differently (data
ot shown).
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